Hepion Pharmaceuticals Stock Quote HEPA - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.7716

Bid

0.7701

Ask

0.7717

Volume

6,450,570

0.75 Day's Range 1.03

0.75 52 Week Range 9.00

Market Cap

5.583M

Previous Close

1.02

Open

1.03

Last Trade

1295

0.7716

Last Trade Time

10:22:13

Financial Volume

$ 5,453,928

VWAP

0.845496

Average Volume (3m)

25,928

Shares Outstanding

5,473,126

Dividend Yield

PE Ratio

-0.11

Earnings Per Share (EPS)

-8.94

Revenue

Net Profit

-48.93M

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.hepion.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Hepion Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HEPA. The last closing price for Hepion Pharmaceuticals was $1.02. Over the last year, Hepion Pharmaceuticals shares have traded in a share price range of $ 0.75 to $ 9.00.

Hepion Pharmaceuticals currently has 5,473,126 shares outstanding. The market capitalization of Hepion Pharmaceuticals is $5.58 million. Hepion Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.11.

Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private Placement

Pharma Two B Ltd. (“Pharma Two B”) has entered into a merger agreement with Hepion Pharmaceuticals, Inc. (“Hepion”) (Nasdaq: HEPA)Immediately upon completion of the merger, current Pharma Two B...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.2684	-25.8076923077	1.04	1.12	0.75	16448	1.04439146	CS
4	-0.2243	-22.5223416006	0.9959	1.12	0.75	17645	1.05205824	CS
12	-0.5784	-42.8444444444	1.35	1.59	0.75	25928	1.17998244	CS
26	-1.3584	-63.7746478873	2.13	3.4899	0.75	53912	1.94751294	CS
52	-8.1484	-91.3497757848	8.92	9	0.75	51232	2.98010168	CS
156	-32.2284	-97.6618181818	33	37	0.75	358720	21.43667372	CS
260	-61.4284	-98.7594855305	62.2	167	0.75	977631	45.68548075	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MIRAMIRA Pharmaceuticals Inc	$ 1.78 (158.42%)	75.57M
CMAXCareMax Inc	$ 3.41 (115.82%)	5.59M
SERVServe Robotics Inc	$ 12.8311 (69.95%)	74.29M
RRRichtech Robotics Inc	$ 2.07 (40.82%)	60.46M
SAVACassava Sciences Inc	$ 12.90 (27.98%)	4.43M
LGCBLinkage Global Inc	$ 3.4901 (-33.08%)	79.25k
HEPAHepion Pharmaceuticals Inc	$ 0.7915 (-22.40%)	6.41M
PSIGPS International Group Ltd	$ 2.6595 (-22.01%)	133.44k
XCURExicure Inc	$ 0.424849 (-20.60%)	1.34M
SISIShineco Inc	$ 0.7634 (-18.79%)	1.23M
NCPLNetcapital Inc	$ 0.121002 (16.35%)	89.05M
MIRAMIRA Pharmaceuticals Inc	$ 1.78 (158.42%)	75.57M
SERVServe Robotics Inc	$ 12.8311 (69.95%)	74.29M
NVDANVIDIA Corporation	$ 121.87 (3.34%)	64.92M
RRRichtech Robotics Inc	$ 2.07 (40.82%)	60.46M